The DOI matches its Crossref record; 72 of the 72 references it cites were found in a registry or an index.
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo
Open accessAbstract
The familial melanoma gene (INK4a/MTS1/CDKN2) encodes potent tumor suppressor activity. Although mice null for the ink4a homolog develop a cancer-prone condition, a pathogenetic link to melanoma susceptibility has yet to be established. Here we report that mice with melanocyte-specific expression of activated H-ras G12V on an ink4a-deficient background develop spontaneous cutaneous melanomas after a short latency and with high penetrance. Consistent loss of the wild-type ink4a allele was observed in tumors arising in ink4a heterozygous transgenic mice. No homozygous deletion of the neighboring ink4b gene was detected. Moreover, as in human melanomas, the p53 gene remained in a wild-type configuration with no observed mutation or allelic loss. These results show that loss of ink4a and activation of Ras can cooperate to accelerate the development of melanoma and provide the first in vivo experimental evidence for a causal relationship between ink4a deficiency and the pathogenesis of melanoma. In addition, this mouse model affords a system in which to identify and analyze pathways involved in tumor progression against the backdrop of genetic alterations encountered in human melanomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Cloning: A Laboratory Manual
Sambrook, J., Fritsch, E., & Maniatis, T. (1989) · UCLA - Biblioteca de Ciencias de la Salud · Cited by 133,589
p53 Mutations in Human Cancers
Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells.
Gorman, C. M., Moffat, L. F., & Howard, B. H. (1982) · Molecular and Cellular Biology · doi:10.1128/mcb.2.9.1044 · Cited by 7,830
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218 · cited 6×
“Along these lines, both p53 and ink4a encode potent growth and tumor suppressive activities and their loss of function correlates with cellular immortalization and transformation by activated Ras ( Serrano et al. 1997 ).”
BackgroundMethodResultInfluentialManipulating the mouse embryo: A laboratory manual
Hogan, B. L. M., Costantini, F. D., & Lacy, E. (1986) · Cited by 4,460
A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.
Serrano, M., Hannon, G. J., & Beach, D. (1993) · Nature · doi:10.1038/366704a0 · Cited by 3,650 · cited 2×
“This region contains the closely linked INK4a and INK4b genes that encode the highly related G1 cyclin-dependent kinase inhibitors, p16Ink4a and p15Ink4b, respectively (Serrano et al. 1993; Hannon and Beach 1994; Kamb et al. 1994; Quelle et al. 1995a).”
BackgroundTumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
Land, H., Parada, L. F., & Weinberg, R. A. (1983) · Nature · doi:10.1038/304596a0 · Cited by 2,804 · cited 2×
“, myc overexpression (Land et al. 1983), loss of ink4a or p53 function (Serrano et al.”
BackgroundA cell cycle regulator potentially involved in genesis of many tumor types
Kamb, A., Gruis, N. A., Weaver-Feldhaus, J., Liu, Q., Harshman, K., Tavtigian, S. V., Stockert, E., Day, R. S., Johnson, B. E., & Skolnick, M. H. (1994) · Science · doi:10.1126/science.8153634 · Cited by 2,751 · cited 8×
“This genomic organization and the common occurrence of large homozygous 9p21 codeletions (Jen et al. 1994; Kamb et al. 1994; Orlow et al. 1995; Flores et al. 1996) hampered initial efforts to evaluate the role of each gene product in melanoma suppression and to assign definitively a melanoma…”
BackgroundInfluentialPurification of Mouse Immunoglobulin Heavy‐Chain Messenger RNAs from Total Myeloma Tumor RNA
AUFFRAY, C., & ROUGEON, F. (1980) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1980.tb06030.x · Cited by 2,627
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
Deng, C., Zhang, P., Wade Harper, J., Elledge, S. J., & Leder, P. (1995) · Cell · doi:10.1016/0092-8674(95)90039-x · Cited by 2,113
pl5INK4B is a potentia| effector of TGF-β-induced cell cycle arrest
Hannon, G. J., & Beach, D. (1994) · Nature · doi:10.1038/371257a0 · Cited by 1,950
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
Role of the INK4a Locus in Tumor Suppression and Cell Mortality
Serrano, M., Lee, H.-W., Chin, L., Cordon-Cardo, C., Beach, D., & DePinho, R. A. (1996) · Cell · doi:10.1016/s0092-8674(00)81079-x · Cited by 1,585
Self-citationNakayama, K., Ishida, N., Shirane, M., Inomata, A., Inoue, T., Shishido, N., Horii, I., Loh, D. Y., & Nakayama, K.-I. (1996) · Cell · doi:10.1016/s0092-8674(00)81237-4 · Cited by 1,547
Ouelle, D. E., Zindy, F., Ashmun, R. A., & Sherr, C. J. (1995) · Cell · doi:10.1016/0092-8674(95)90214-7 · Cited by 1,485
Fero, M. L., Rivkin, M., Tasch, M., Porter, P., Carow, C. E., Firpo, E., Polyak, K., Tsai, L.-H., Broudy, V., Perlmutter, R. M., et al. (1996) · Cell · doi:10.1016/s0092-8674(00)81239-8 · Cited by 1,457
PKD2 , a Gene for Polycystic Kidney Disease That Encodes an Integral Membrane Protein
Mochizuki, T., Wu, G., Hayashi, T., Xenophontos, S. L., Veldhuisen, B., Saris, J. J., Reynolds, D. M., Cai, Y., Gabow, P. A., Pierides, A., et al. (1996) · Science · doi:10.1126/science.272.5266.1339 · Cited by 1,406
Clinical Implications of the p53 Tumor-Suppressor Gene
Harris, C. C., & Hollstein, M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310283291807 · Cited by 1,330
Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
Lee, E. Y.-H. P., Chang, C.-Y., Hu, N., Wang, Y.-C. J., Lai, C.-C., Herrup, K., Lee, W.-H., & Bradley, A. (1992) · Nature · doi:10.1038/359288a0 · Cited by 1,265
Enhanced Growth of Mice Lacking the Cyclin-Dependent Kinase Inhibitor Function of p27
Kiyokawa, H., Kineman, R. D., Manova-Todorova, K. O., Soares, V. C., Hoffman, E. S., Ono, M., Khanam, D., Hayday, A. C., Frohman, L. A., & Koff, A. (1996) · Cell · doi:10.1016/s0092-8674(00)81238-6 · Cited by 1,251
Requirement for a functional Rb-1 gene in murine development
Clarke, A. R., Maandag, E. R., van Roon, M., van der Lugt, N. M. T., van der Valk, M., Hooper, M. L., Berns, A., & te Rielef, H. (1992) · Nature · doi:10.1038/359328a0 · Cited by 1,008
Germline p16 mutations in familial melanoma
Hussussian, C. J., Struewing, J. P., Goldstein, A. M., Higgins, P. A. T., Ally, D. S., Sheahan, M. D., Clark, W. H., Tucker, M. A., & Dracopoli, N. C. (1994) · Nature Genetics · doi:10.1038/ng0994-15 · Cited by 977
Mutations of cell cycle regulators. Biological and clinical implications for human neoplasia.
Cordon‐Cardo, C. (1995) · PubMed · Cited by 607
Self-citationTakayama, H., LaRochelle, W. J., Sharp, R., Otsuka, T., Kriebel, P., Anver, M., Aaronson, S. A., & Merlino, G. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.701 · Cited by 440
Role of the cyclin-dependent kinase inhibitors in the development of cancer
Hirama, T., & Koeffler, H. (1995) · Blood · doi:10.1182/blood.v86.3.841.841 · Cited by 418
Steel, K. P., & Barkway, C. (1989) · Development · doi:10.1242/dev.107.3.453 · Cited by 412
Deletion of p16 and p15 genes in brain tumors.
Jen, J., Harper, J. W., Bigner, S. H., Bigner, D. D., Papadopoulos, N., Markowitz, S. D., Willson, J. K. V., Kinzler, K. W., & Vogelstein, B. (1994) · PubMed · Cited by 404
Complex structure and regulation of the P16 (MTS1) locus.
Stone, S., Jiang, P., Dayananth, P., Tavtigian, S. V., Katcher, H. L., Parry, D., Peters, G., & Kamb, A. (1995) · PubMed · Cited by 383
Transforming ras genes from human melanoma: a manifestation of tumour heterogeneity?
Albino, A. P., Strange, R. L., Oliff, A. I., Furth, M. E., & Old, L. J. (1984) · Nature · doi:10.1038/308069a0 · Cited by 324
Homozygotes for CDKN2 (p16) germline mutation in Dutch familial melanoma kindreds
Gruis, N. A., van der Velden, P. A., Sandkuijl, L. A., Prins, D. E., Weaver-Feldhaus, J., Kamb, A., Bergman, W., & Frants, R. R. (1995) · Nature Genetics · doi:10.1038/ng0795-351 · Cited by 310
Cell-cycle regulators and cancer
Kamb, A. (1995) · Trends in Genetics · doi:10.1016/s0168-9525(00)89027-7 · Cited by 284
N-ras mutations in human cutaneous melanoma from sun-exposed body sites.
van 't Veer, L. J., Burgering, B. M., Versteeg, R., Boot, A. J., Ruiter, D. J., Osanto, S., Schrier, P. I., & Bos, J. L. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.7.3114 · Cited by 283
Cloning and characterization of murine p16INK4a and p15INK4b genes.
Quelle, D. E., Ashmun, R. A., Hannon, G. J., Rehberger, P. A., Trono, D., Richter, K. H., Walker, C., Beach, D., Sherr, C. J., & Serrano, M. (1995) · PubMed · Cited by 235
RAS Mutations in Human Melanoma: A Marker of Malignant Progression
Ball, N. J., Yohn, J. J., Morelli, J. G., Norris, D. A., Golitz, L. E., & Hoeffler, J. P. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12371783 · Cited by 221
Quelle, D. E., Cheng, M., Ashmun, R. A., & Sherr, C. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.669 · Cited by 220
Albino, A. P., Nanus, D. M., Mentle, I. R., Cordon‐Cardo, C., McNutt, N. S., Bressler, J., & Andreeff, M. (1989) · PubMed · Cited by 212
Self-citationFitzGerald, M. G., Harkin, D. P., Silva-Arrieta, S., MacDonald, D. J., Lucchina, L. C., Unsal, H., O'Neill, E., Koh, J., Finkelstein, D. M., Isselbacher, K. J., et al. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.16.8541 · Cited by 200
p27/Kip1 mutation found in breast cancer.
Spirin, K. S., Simpson, J., Takeuchi, S., Kawamata, N., Cw, M., & Koeffler, H. P. (1996) · PubMed · Cited by 190
Deletion of the p16 and p15 Genes in Human Bladder Tumors
Orlow, I., Lacombe, L., Hannon, G. J., Serrano, M., Pellicer, I., Dalbagni, G., Reuter, V. E., Zhang, Z.-F., Beach, D., & Cordon-Cardo, C. (1995) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/87.20.1524 · Cited by 184
Self-citationLoss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma.
Flores, J. F., Walker, G. J., Glendening, J. M., Haluska, F. G., Castresana, J. S., Rubio, M., Pastorfide, G. C., Boyer, L. A., Kao, W. H., Bulyk, M. L., et al. (1996) · PubMed · Cited by 169
Tan, T. H., Wallis, J., & Levine, A. J. (1986) · Journal of Virology · doi:10.1128/jvi.59.3.574-583.1986 · Cited by 162
Malignant melanoma in transgenic mice.
Bradl, M., Klein–Szanto, A. J., Porter, S. D., & Mintz, B. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.1.164 · Cited by 152
Lifetime risk for development of skin cancer in the U.S. population: Current estimate is now 1 in 5
Rigel, D. S., Friedman, R. J., & Kopf, A. W. (1996) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(96)90139-5 · Cited by 145
Iwamoto, T., Takahashi, M., Ito, M. A., Hamatani, K., Ohbayashi, M., Wajjwalku, W., Isobe, K.-I., & Nakashima, I. (1991) · The EMBO Journal · doi:10.1002/j.1460-2075.1991.tb04878.x · Cited by 129
Hangaishi, A., Ogawa, S., Imamura, N., Miyawaki, S., Miura, Y., Uike, N., Shimazaki, C., Emi, N., Takeyama, K., Hirosawa, S., et al. (1996) · Blood · doi:10.1182/blood.v87.12.4949.bloodjournal87124949 · Cited by 127
Ganss, R., Montoliu, L., Monaghan, A. P., & Schütz, G. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06607.x · Cited by 125
A question of balance: the role of cyclin-kinase inhibitors in development and tumorigenesis
Elledge, S. J., Winston, J. T., & Harper, J. W. (1996) · Trends in Cell Biology · doi:10.1016/0962-8924(96)10030-1 · Cited by 120
Absence of p53 Gene Mutations in Cutaneous Melanoma
Lübbe, J., Reichel, M., Burg, G., & Kleihues, P. (1994) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12381544 · Cited by 113
Davies, R. L., Grosse, V. A., Kucherlapati, R., & Bothwell, M. A. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.7.4188 · Cited by 106
Somatic mutations of the WAF1/CIP1 gene in primary prostate cancer.
Gao, X., Chen, Y. Q., Wu, N., Grignon, D. J., Sakr, W., Porter, A. T., & Honn, K. V. (1995) · PubMed · Cited by 106
Tremblay, P., Pothier, F., Hoang, T., Tremblay, G. A., Brownstein, S., Liszauer, A., & Jolicoeur, P. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.2.854 · Cited by 95
Jafari, M., Papp, T., Kirchner, S., Kiener, U., Henschler, D., Burg, G., & Schiffmann, D. (1995) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01202725 · Cited by 94
Powell, M. B., Hyman, P., Bell, O. D., Balmain, A., Brown, K., Alberts, D., & Bowden, G. T. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940120205 · Cited by 84
Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas
Vidal, M. J., Loganzo, F., Oliveira, A. R., Hayward, N. K., & Albino, A. P. (1995) · Melanoma Research · doi:10.1097/00008390-199508000-00006 · Cited by 80
Kinoshita, I., Dosaka‐Akita, H., Mishina, T., Akie, K., Nishi, M., Hiroumi, H., Hommura, F., & Kawakami, Y. (1996) · PubMed · Cited by 78
Heinzel, P. A., Balaram, P., & Bernard, H. (1996) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19961115)68:4<420::aid-ijc3>3.0.co;2-2 · Cited by 73
Glendening, J. M., Flores, J. F., Walker, G. J., Stone, S., Albino, A. P., & Fountain, J. W. (1995) · PubMed · Cited by 69
A mutant p21 cyclin-dependent kinase inhibitor isolated from a Burkitt's lymphoma.
Bhatia, K. G., Fan, S., Spangler, G., Weintraub, M., O'Connor, P. M., Judde, J., & MAGRATH, I. T. (1995) · PubMed · Cited by 66
The Xmrk receptor tyrosine kinase is activated in Xiphophorus malignant melanoma.
Wittbrodt, J., Lammers, R., Malitschek, B., Ullrich, A., & Schartl, M. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05518.x · Cited by 64
Albino, A. P., Sozzi, G., Nanus, D. M., Jhanwar, S. C., & Houghton, A. N. (1992) · PubMed · Cited by 64
Preferential loss of expression of p16(INK4a) rather than p19(ARF) in breast cancer.
Brenner, A. J., Paladugu, A. V., Wang, H., Olopade, O. I., Dreyling, M. H., & Aldaz, C. M. (1996) · PubMed · Cited by 58
Lack ofp53 mutations and loss of heterozygosity in non-cultured human melanocytic lesions
Papp, T., Jafari, M., & Schiffmann, D. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01213550 · Cited by 57
Wilson, R. E., Dooley, T. P., & Hart, I. R. (1989) · PubMed · Cited by 56
y Cajal, S. R., Suster, S. M., Halaban, R., Filvaroff, E. H., & Dotto, G. P. (1991) · PubMed · Cited by 41
The current situation with regard to human melanoma and genetic inferences
Hayward, N. K. (1996) · Current Opinion in Oncology · doi:10.1097/00001622-199603000-00011 · Cited by 37
Analysis of p21WAF1/CIP1 in primary bladder tumors.
Lacombe, L., Orlow, I., Silver, D. A., Wl, G., Fair, W. R., Reuter, V. E., & Cordon‐Cardo, C. (1996) · PubMed · Cited by 36
Self-citationRas Gene Mutation: A Rare Event in Nonmetastatic Primary Malignant Melanoma
Wagner, S. N., Ockenfels, H. M., Wagner, C., Höfler, H., & Goos, M. (1995) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12607039 · Cited by 33
Analysis of viral-host protein interactions and tumorigenesis in transgenic mice.
Ta, V. D. (1994) · PubMed · Cited by 31
Newcomb, E. W., Rao, L. S., Giknavorian, S. S., & Lee, S. Y. (1995) · Molecular Carcinogenesis · doi:10.1002/mc.2940140302 · Cited by 25
p16ink4aGene and Hematological Malignancies
Quesnel, B., Preudhomme, C., & Fenaux, P. (1996) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.3109/10428199609051724 · Cited by 25
Huang, T., Rauth, S., & Gupta, T. K. D. (1996) · PubMed · Cited by 23
Cited by
The RB and p53 pathways in cancer
Sherr, C. J., & McCormick, F. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00102-2 · Cited by 1,690
“However, mice lacking Ink4a-Arf rarely develop melanoma unless crossed with animals that express a Ras transgene in appropriate target cells ( Chin et al., 1997; Bardeesy et al., 2001).When animals containing a mutant Ink4a allele were crossed with mice lacking the entire Ink4a-Arf locus, heterozygotes spontaneously d…”
BackgroundGenetics and biology of pancreatic ductal adenocarcinoma
Hezel, A. F., Kimmelman, A. C., Stanger, B. Z., Bardeesy, N., & DePinho, R. A. (2006) · Genes & Development · doi:10.1101/gad.1415606 · Cited by 1,577
Self-citationPomerantz, J., Schreiber-Agus, N., Liégeois, N. J., Silverman, A., Alland, L., Chin, L., Potes, J., Chen, K., Orlow, I., Lee, H.-W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81400-2 · Cited by 1,521
Self-citationMiller, A. J., & Mihm, M. C. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052166 · Cited by 1,339
Pancreatic cancer biology and genetics
Bardeesy, N., & DePinho, R. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc949 · Cited by 1,142
Self-citation
Metadata
- Authors
- Chin, L., Pomerantz, J., Polsky, D., Jacobson, M., Cohen, C., Cordon-Cardo, C., Horner, J. W., & DePinho, R. A.
- Venue
- Genes & Development
- Publisher
- Cold Spring Harbor Laboratory
- Published
- 1997-11-01
- Volume
- 11
- Issue
- 21
- Pages
- 2822-2834
- ISSN
- 0890-9369 (ISSN-L)
- 1549-5477
- OpenAlex
- W2147822352
- Cited by
- 402
- References
- 72
- Type
- posted content
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.